characteristics.text: ERC000026
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: 2022-03-01T16:29:21Z
characteristics.characteristic: ENA-FIRST-PUBLIC
characteristics.text: 2022-03-01T16:29:21Z
characteristics.characteristic: ENA-LAST-UPDATE
characteristics.text: SAMEA12220809
characteristics.characteristic: External Id
characteristics.text: Erasmus University Medical Center, Cancer Institute, Josephine Nefkens Building, Rotterdam; Princess Maxima Center for Pediatric Oncology
characteristics.characteristic: INSDC center name
characteristics.text: 2022-03-01T16:29:21Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-03-01T16:29:21Z
characteristics.characteristic: INSDC last update
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS9817791
characteristics.characteristic: SRA accession
characteristics.text: NCCIT_R_SK
characteristics.characteristic: Submitter Id
characteristics.text: human
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: common name
characteristics.text: Resistant germ cell tumor cell line to cisplatin generated in Slovakia.
characteristics.characteristic: description
characteristics.text: male
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/PATO_0000384
characteristics.characteristic: gender
characteristics.text: Homo sapiens
characteristics.characteristic: organism
characteristics.text: Cisplatin resistant
characteristics.characteristic: phenotype
characteristics.text: Homo sapiens
characteristics.characteristic: scientific_name
characteristics.text: NCCIT_R_SK
characteristics.characteristic: subject id
characteristics.text: NCCIT_R_SK
characteristics.characteristic: title